Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis

CR Goncalves, AS Vasconcellos, TR Rodrigues… - Reproductive …, 2022 - Elsevier
The aim of this systematic review and meta-analysis was to evaluate the effectiveness of
different hormone therapies, including hormonal contraceptives, in women with premature …

[HTML][HTML] Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 …

IF Godsland - Fertility and sterility, 2001 - Elsevier
Objective: To establish reference estimates of the effects of different hormone replacement
therapy (HRT) regimens on lipid and lipoprotein levels. Design: Review and pooled analysis …

The effect of transdermal 17β-estradiol combined with norethisterone acetate treatment on the lipid profile in postmenopausal women: a meta-analysis and systematic …

W Tao, X Cai, MK Al Masri, MA Găman, K Prabahar… - Steroids, 2022 - Elsevier
Background and aim The effect of transdermal 17β-estradiol and norethisterone acetate co-
administration on the lipid profile in postmenopausal women remains controversial as …

Cardiovascular risk factors in premature ovarian insufficiency using hormonal therapy

GP Rezende, T Dassie, DAY Gomes… - Revista Brasileira de …, 2023 - thieme-connect.com
Objective Premature ovarian insufficiency (POI) is characterized by early hypoestrogenism.
An increased risk of cardiovascular (CV) disease is a long-term consequence of POI. A …

Cardiovascular disease risk among transgender people with HIV

M Cetlin, ES Fulda, SM Chu, OPR Hamnvik… - Current HIV/AIDS …, 2021 - Springer
Abstract Purpose of Review Transgender individuals are at disproportionate risk for HIV
infection, with prevalence rates highest among transgender women of color. Antiretroviral …

Effect of oestrogen replacement therapy on serum lipid profile

S Nanda, N Gupta, HC Mehta… - Australian and New …, 2003 - Wiley Online Library
Background: Oestrogen deficiency in postmenopausal women alters the lipid metabolism
unfavourably. Aim: To evaluate the effects of oral and transdermal oestrogen replacement …

[HTML][HTML] Dietary cholesterol intake and stroke risk: a meta-analysis

P Cheng, J Pan, J Xia, F Deng, W Huang, S Bai… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Results Seven prospective studies including 269,777 non-overlapping individuals (4,604
strokes) were included. The combined RR of stroke for higher cholesterol intake (> 300 …

[PDF][PDF] Everything in moderation: investigating the U-shaped link between HDL cholesterol and adverse outcomes

MP Allard-Ratick, P Sandesara… - US Cardiol …, 2019 - assets.radcliffecardiology.com
Despite historical evidence suggesting an inverse association between HDL cholesterol
(HDL-C) and adverse cardiovascular events, pharmacological efforts to increase HDL-C and …

Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women

F Sendag, N Karadadas, S Ozsener… - Archives of gynecology and …, 2002 - Springer
The aim of this study was to compare the effects of sequential combined transdermal and
oral postmenopausal hormone replacement therapies on serum lipid-lipoprotein profiles risk …

Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels

LCN Erberich, VM Alcântara, G Picheth, M Scartezini - 2002 - degruyter.com
Postmenopausal women run the same risks of coronary heart disease as men. The lipid
alterations observed at this time reflect increased blood levels of total cholesterol, low …